Daily aspirin offers little to no benefit for most adults trying to prevent heart disease, new report says
Taking low-dose aspirin every day to prevent a heart attack or stroke provides little to…
Author: STAT
STAT+: Manchin won’t support new health policy unless Congress rolls back Trump tax cuts
WASHINGTON — Sen. Joe Manchin, a moderate Democrat who will determine how much domestic policy…
The FDA’s ban on menthol in cigarettes clears a major regulatory hurdle
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine….
Global coalition seeks $4.8 billion for polio eradication initiative
The Global Polio Eradication Initiative said Tuesday that it is seeking $4.8 billion to fund…
STAT+: Pharmalittle: White House announces Covid-pill push; ‘right-to-try’ think tank is back with a new law
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: Biofourmis raises $300 million as it looks to drive adoption of remote care
Biofourmis has spent years trying to figure out how to help care for patients with…
Biden administration starts Covid treatment push, focusing on Pfizer’s Paxlovid
The Biden administration announced a series of initiatives Tuesday aimed at increasing the use of…
Opinion: How hospitals and health systems can help patients avoid medical debt
While the goal of the American health care system is to improve health and well-being,…
He had an M.D. and a Ph.D. but didn’t match into a residency. It was the push he needed to jump into health tech
Travis Hughes had been assured by both mentors and peers that he was a front-runner…
Experts fear U.S. may default to annual Covid boosters without sufficient data
A number of vaccine experts are concerned the United States may be sleepwalking into a…
STAT+: Right to try 2.0: Advocates want to reduce oversight of ‘n of 1’ therapies
WASHINGTON — The libertarian think tank behind the federal “right-to-try” law is back at it…
STAT+: Thanks to Covid-19, pharma’s reputation improved among patient groups. But can it last?
Thanks to its response to the Covid-19 pandemic, the pharmaceutical industry has greatly improved its…
STAT+: Biden is urged to pursue march-in rights for a pricey cancer drug after NIH delays a petition review
Citing arguments by more than two dozen legal experts, Sen. Elizabeth Warren (D-Mass.) is urging…
STAT+: One in four pharma status reports on follow-up trials are late or aren’t filed
Drug companies failed to submit 11% of status reports for clinical trials they were required…
Majority of family members of Covid patients treated in the ICU report PTSD symptoms
A majority of family members of Covid-19 patients treated in ICUs reported significant symptoms of…
STAT+: Pharma R&D payments to European researchers are like ‘dark money’
Due to inadequate disclosure policies, drug company payments to European researchers and institutions for R&D…
STAT+: Pharmalittle: Are new ADHD treatments really any better? India moves to reduce dependence on China for pharma ingredients
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Nkarta studies of engineered natural killer cells show complete remissions in patients with blood cancers
Nkarta said Monday that two experimental, off-the-shelf treatments, both made from engineered natural killer cells,…
Opinion: Wearable device data need to represent all of us
The growing uptake of wearable devices has sparked enthusiasm among health researchers, and for good…
Opinion: Expedited partner therapy is an effective way to treat sexually transmitted infections. Why aren’t doctors using it?
As emergency medicine and infectious disease physicians, we often see patients with chlamydia, gonorrhea, and…
STAT+: There’s a new crop of treatments for ADHD in kids. Are they any better?
Parents and doctors now have more tools than ever before to help kids manage symptoms…
White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process
WASHINGTON — It was a striking visual for the television cameras. White House Press Secretary…
What science journalism can’t tell us about Covid-19 deaths
In the first piece of science journalism I ever wrote, I compared deciphering the effects…
.jpg)
WHO says 12 countries have reported unusual cases of hepatitis in kids
The World Health Organization said Saturday that 12 countries have reported at least 169 unusual…
STAT+: Travel nurses remain pricey, and it’s weighing on hospital profits
An underwhelming first quarter at the country’s biggest hospital chain shows the pandemic’s stranglehold on…
Opinion: In mask mandate case, judge ruled on wordplay, not public health
When a Tampa-based federal judge voided the nationwide mandate on wearing masks in transportation venues…
STAT+: Pharmalittle: U.S. health agency workers fail to report political interference; Canada walks back some drug-pricing reforms
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Access to kidney transplantation is improving for everyone, but more work remains to be done
Organ donation and transplantation are saving more lives in the United States than ever before,…
Opinion: It’s time for Congress to stop blocking mitochondrial replacement therapy
Australia has become the second country in the world to explicitly authorize and regulate mitochondrial…
STAT+: With milestones on the horizon, Guardant Health CEOs lay out their vision for cancer detection
SAN DIEGO — Bay Area biotech Guardant Health is closer than ever to its ultimate…
A new nonprofit wants to rewrite the playbook for how the U.S. government funds science
WASHINGTON — The Good Science Project is hoping to push the NIH and other government…
Health tech funding from consumers, a breakthrough breakdown, & new hires
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Listen: An ominous biotech deal, vaccines for kids, & ‘breakthrough’ devices
Can buyouts be bad news? Why can’t Novavax meet a deadline? And what does “breakthrough”…
N.C. becomes second U.S. state to report unusual cases of hepatitis in kids
Health authorities in North Carolina say they are investigating two cases of hepatitis in young…
For kids with Down syndrome, a new device offers hope for treating difficult sleep problems
Kate Dougherty pairs all of her son Eliot’s doctor’s appointments with a treat, like a…
STAT+: CDC, FDA, and NIH staffers aren’t reporting political interference, new watchdog report shows
WASHINGTON — Staff at the nation’s health agencies suspect political interference is inappropriately influencing government…
STAT+: Multiple myeloma is usually detected late. Some researchers think a precursor could help catch it early
For all the recent advances in treating multiple myeloma, scientists have only inched forward in…
STAT+: Pharmalittle: U.S. spending on medicines rose 12% last year; Louisiana sues a PBM for allegedly overcharging
Top of the morning to you. And a fine one it is. Blue skies and…
STAT+: U.S. spending on pharmaceuticals jumped 12% in 2021, fueled by costs of Covid-19 vaccines and therapies
Thanks to Covid-19 vaccines and therapies, U.S. spending on pharmaceuticals rose 12% in 2021 as…
Opinion: STAT+: Pharma’s role in value-based care starts with value-based research
Modern medicine has been sculpted by the ever-expanding knowledge of biological processes in conjunction with…
.jpg)
Opinion: Will the shadow of Aduhelm cloud FDA’s decision-making on an ALS therapy?
On March 30, an FDA advisory panel voted 6 to 4 against recommending approval of…
A psychedelic therapist allegedly took millions from a Holocaust survivor, highlighting worries about elders taking hallucinogens
He made a new life for himself in California. After surviving the Holocaust and growing…
STAT+: Endo wins a reprieve in an opioid lawsuit in Tennessee as appeals court overturns sanctions
Endo International won a key battle over its role in the opioid crisis in Tennessee…
STAT+: Louisiana accuses UnitedHealth and its OptumRx PBM of inflating drug costs for its Medicaid program
In the latest bid to pull back the curtain on pharmacy benefit managers, the Louisiana…
STAT+: Pfizer faces criticism for arguing that intellectual property for its Covid-19 pill is a human right
Numerous advocacy groups and institutional shareholders are chiding Pfizer for arguing that its intellectual property…
Virtual Event: A Conversation with the STAT Madness Crowd Favorite
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Glaxo workers in the U.K. vote to strike; Alabama reaches $276 million deal over opioid crisis
Hello, everyone, and welcome to the middle of the week. You made it this far,…
Opinion: Not going all in on the 988 hotline will ensure its failure
Time is not on our side. With fewer than 100 days until the scheduled rollout…
Opinion: Listen: Covid turned the nation’s eyes to nursing homes. Have we already looked away?
When the Covid-19 pandemic began tearing across the country, it hit nursing homes hard. More…
STAT+: What counts as a breakthrough? 8 insights on the FDA’s approach to medical devices
The word breakthrough carries a kind of weight: It’s a dramatic step forward, a critical…